Process R&D is the critical bridge between promising discovery chemistry and a robust, scalable, cost-conscious manufacturing route. For pharmaceutical and biotechnology teams, the challenge is rarely limited to making a target molecule once; the real need is to build a reproducible process that controls impurities, improves yield, reduces difficult operations, supports material supply, and can be transferred smoothly to larger-scale production. BOC Sciences provides integrated Process R&D services for small molecules, intermediates, specialty building blocks, peptides, and complex synthetic compounds. Our scientists combine route design, experimental optimization, analytical insight, crystallization control, impurity investigation, and scale-up engineering to help clients transform early synthetic routes into practical processes with clearer risk profiles and stronger development value.
BOC Sciences supports route scouting and development for drug substance and intermediate projects where the original medicinal chemistry route is too long, costly, hazardous, low-yielding, or difficult to scale.
Our chemists apply systematic reaction condition optimization to improve conversion, yield, selectivity, impurity control, and process consistency across key synthetic steps.
Through practical scale-up studies, BOC Sciences evaluates how a reaction behaves beyond small glassware, focusing on mixing, heat transfer, addition control, isolation, filtration, and drying performance.
We integrate impurity profiling, impurity isolation and identification, and process analytics to understand where impurities originate and how they can be controlled.
From route redesign to kilogram-scale process demonstration, BOC Sciences helps pharmaceutical teams reduce synthetic risk, improve process understanding, and obtain development-ready material.
We develop practical synthetic routes for APIs, intermediates, and advanced building blocks, integrating custom synthesis, API synthesis, and intermediate preparation expertise into one coordinated workflow.
Our process optimization work focuses on measurable improvements in conversion, selectivity, yield, productivity, solvent use, workup efficiency, and batch-to-batch reproducibility.
We design crystallization and isolation strategies through crystallization services, solvent selection, cooling profiles, anti-solvent addition, seeding studies, and slurry aging evaluation.
For compounds sensitive to form changes, we combine polymorph screening, salt form screening, and drying studies to improve isolation behavior and physical consistency.
For reactions limited by heat transfer, mixing, hazardous intermediates, or short residence times, our flow chemistry services and continuous flow reaction technology support safer and more controlled process options.
BOC Sciences supports Process R&D across early route evaluation, candidate-focused synthesis, material supply, route improvement, process troubleshooting, and scale-up preparation. Our services can be engaged as a focused study on a single problematic step or as an integrated development program covering route design, optimization, analytics, impurity control, isolation, and batch production.
Share your target structure, current route, bottleneck step, impurity concern, or desired batch size. BOC Sciences will evaluate the chemistry and recommend a practical Process R&D plan.
We review the target structure, existing synthetic route, reaction data, analytical results, impurity observations, material requirements, and known bottlenecks. This stage defines the development objective, whether it is yield improvement, route shortening, impurity control, scale-up readiness, or alternative route discovery.
Our scientists design focused experiments covering solvents, reagents, catalysts, temperature profiles, order of addition, concentration, crystallization conditions, and purification options. Parallel screening and targeted analytics help identify high-impact variables quickly while conserving valuable starting material.
Promising conditions are refined through repeated reaction monitoring, impurity tracking, mass balance analysis, and isolation studies. Where needed, we support method development and analytical method optimization to ensure the process can be evaluated with confidence.
The optimized process is demonstrated at an appropriate batch size, with attention to mixing, heat control, filtration, washing, drying, and product consistency. We provide a clear technical package containing procedures, observations, analytical results, impurity notes, and scale-up recommendations.
Early discovery routes often rely on expensive reagents, dilute conditions, column chromatography, unstable intermediates, or operations that become impractical beyond small scale. BOC Sciences redesigns these routes by comparing alternative bond-forming strategies, replacing problematic steps, and improving isolation logic so that clients can obtain material through a more reliable and development-oriented process.
When a key step shows variable conversion or unpredictable impurity formation, our team investigates reaction sensitivity to moisture, temperature, concentration, reagent quality, catalyst loading, and mixing. We then establish a more controlled operating window through repeated experiments, reaction monitoring, and practical parameter selection that can be applied consistently at larger batch sizes.
Unknown impurities can delay material use, complicate purification, and indicate hidden weaknesses in the chemistry. BOC Sciences applies process impurities analysis, isolation, structural identification, and formation-pathway studies to determine whether impurities arise from starting materials, reagents, side reactions, degradation, or downstream carryover, then modifies the process accordingly.
A route is not truly scalable if the product can only be obtained through repeated chromatography or fragile manual handling. We improve purification through analysis/purification, chemical purification methods, crystallization design, salt formation, slurry washing, solvent exchange, and large scale separation strategies.
Collaborate with BOC Sciences to advance your route from exploratory synthesis to a more efficient, better-understood, and scale-conscious process supported by experienced chemists and analytical scientists.
We support challenging bond formations through catalyst screening, ligand evaluation, reaction tuning, metal catalysis technology, asymmetric synthesis, and chiral synthesis strategies.
In-process sampling and time-course analysis help determine conversion trends, intermediate buildup, degradation pathways, and impurity growth. These insights guide parameter selection and prevent optimization from becoming a trial-and-error exercise.
Our solubility analysis and solid-state studies help select solvents, anti-solvents, isolation conditions, and drying approaches that improve recovery, crystal behavior, and downstream handling.
When projects move from optimization to material supply, BOC Sciences connects Process R&D with small molecule API development and API manufacturing services to maintain continuity of chemistry knowledge.
Client Needs: A biotechnology client needed gram-to-hundred-gram supply of a substituted bicyclic heteroaryl intermediate for a kinase inhibitor program. The discovery route used six steps, two chromatographic purifications, and an unstable aldehyde intermediate that decomposed during storage.
Challenges: The original route delivered variable yield and required low-temperature handling during the key condensation step. A practical alternative route was needed to reduce isolation burden, improve intermediate stability, and support repeated batch preparation.
Solution: BOC Sciences performed retrosynthetic comparison of three routes, screened eight coupling conditions, and replaced the unstable aldehyde isolation with a telescoped oxidation-condensation sequence. We optimized solvent exchange, crystallization, and slurry washing, then completed three 50 g confirmation batches with reaction monitoring and impurity tracking across each step.
Outcome: The redesigned route reduced chromatographic purification to one final polish, improved overall isolated yield by 34%, and produced a stable crystalline intermediate suitable for further synthetic development.
Client Needs: A pharmaceutical research group observed a recurring late-eluting impurity during synthesis of a chiral amide API intermediate. The impurity increased during workup and complicated downstream purification even when the main reaction showed high conversion.
Challenges: The impurity was not commercially available and its formation mechanism was unclear. The team needed structural identification, a practical reduction strategy, and an analytical method capable of tracking the impurity at multiple process stages.
Solution: We enriched the impurity by modified preparative HPLC, assigned its structure using LC-MS/MS and NMR, and confirmed formation through a stress study of quench pH, residual acid, and hold time. BOC Sciences then adjusted quench temperature, buffering sequence, and extraction solvent, running 18 experiments to define a robust control window.
Outcome: The impurity level was substantially reduced during the workup stage, the product isolation became more predictable, and the client received an impurity formation rationale with a practical monitoring method.
Client Needs: A project team required scale-up of a poorly soluble macrocyclic peptide-like small molecule from 2 g discovery batches to 200 g development batches. The final isolation suffered from slow filtration, broad particle size distribution, and inconsistent residual solvent removal.
Challenges: The compound formed dense, compressible solids after anti-solvent addition, creating long filtration times and inconsistent drying. A better isolation process was necessary without changing the molecular structure or compromising assay performance.
Solution: BOC Sciences evaluated six solvent/anti-solvent systems, three seeding approaches, and controlled addition profiles using focused crystallization studies. We selected a mixed-solvent slurry aging process, optimized agitation and temperature ramps, and tested filtration on multiple filter media before producing two 200 g demonstration batches with full analytical comparison.
Outcome: The optimized isolation reduced filtration time, improved particle uniformity, and delivered consistent dry solid suitable for subsequent formulation research and development use.
Process R&D transforms an early synthetic route into a more reliable, scalable, and cost-effective manufacturing process. It focuses on route evaluation, reaction optimization, impurity understanding, isolation strategy, solvent selection, and process robustness. For drug development teams, the goal is not only to make the molecule, but to establish a reproducible process that can support increasing material demand with better control over yield, quality, safety, and operational efficiency.
Process R&D is important because many discovery-stage routes are designed for speed, not scalability. These routes may rely on expensive reagents, difficult purifications, low-yielding steps, or conditions that become problematic at larger scale. A well-designed Process R&D program identifies weak points early, improves critical reaction steps, reduces avoidable impurities, and creates a clearer technical path from laboratory preparation to larger-scale production.
Process R&D should begin when a compound shows strong development potential and the project requires larger, more consistent material supply. Starting early helps teams avoid carrying forward an inefficient or fragile route. By evaluating alternative routes, optimizing key steps, and understanding impurity behavior before major scale-up activities, BOC Sciences helps clients reduce technical uncertainty and build a stronger foundation for subsequent development work.
Process R&D may include route scouting, reaction condition screening, design of experiments, impurity identification, intermediate characterization, crystallization development, workup optimization, solvent replacement, process safety assessment, and scale-up experiments. The exact study package depends on the molecule, project stage, and technical bottlenecks. BOC Sciences designs customized workflows to address route efficiency, reproducibility, impurity control, and process transferability.
Impurity control in Process R&D starts with understanding where impurities come from and how they behave during synthesis, workup, and isolation. Scientists examine reaction pathways, degradation risks, raw material contributions, and purification windows. By adjusting temperature, pH, solvent system, reagent stoichiometry, addition sequence, reaction endpoint, and crystallization parameters, BOC Sciences helps reduce impurity formation and improve removal efficiency throughout the process.
BOC Sciences did more than repeat our discovery route. Their team identified where the chemistry would fail at larger scale and proposed a cleaner, more practical sequence that immediately improved our material supply plan.
— Senior Director of Chemistry, US Biotechnology Company
We had an impurity problem that looked unpredictable internally. BOC Sciences isolated the impurity, explained its formation pathway, and translated that knowledge into a process adjustment we could actually use.
— Process Chemistry Lead, European Pharmaceutical Group
The optimization study was well organized and data-rich. Their chemists balanced reaction performance with workup practicality, which helped us avoid a high-yielding but unrealistic laboratory process.
— CMC Project Manager, Emerging Pharma Company
Our compound had poor isolation behavior, and scale-up was becoming a major bottleneck. BOC Sciences improved crystallization and filtration through a logical, experiment-based approach that gave us confidence for the next batch.
— Head of Drug Substance Development, Specialty Therapeutics Team
If you have any questions or encounter issues on this page, please don't hesitate to reach out. Our support team is ready to assist you.
